Home › Funds › MFS Investment Management › ASND
MFS Investment Management position in ASND
ASCENDIS PHARMA A/S · Health Care
Latest position (Q2 2026)1.88M sh
Reported value held$500.14M
Portfolio Weight0.17%
First reportedQ2 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2021 | 700.44K | $92.14M | New |
| Q3 2021 | 743.98K | $118.58M | Add |
| Q4 2021 | 752.30K | $101.21M | Add |
| Q2 2022 | 835.20K | $77.64M | Add |
| Q3 2022 | 1.18M | $122.30M | Add |
| Q4 2022 | 1.34M | $164.09M | Add |
| Q1 2023 | 1.36M | $145.56M | Add |
| Q2 2023 | 1.09M | $97.06M | Reduce |
| Q3 2023 | 1.26M | $118.40M | Add |
| Q4 2023 | 1.52M | $191.35M | Add |
| Q1 2024 | 1.62M | $244.57M | Add |
| Q2 2024 | 1.71M | $233.35M | Add |
| Q3 2024 | 1.87M | $278.76M | Add |
| Q4 2024 | 1.87M | $257.11M | Hold |
| Q1 2025 | 1.88M | $292.69M | Add |
| Q2 2025 | 1.90M | $328.26M | Add |
| Q3 2025 | 1.88M | $374.32M | Reduce |
| Q4 2025 | 1.89M | $402.25M | Hold |
| Q1 2026 | 1.86M | $425.57M | Reduce |
| Q2 2026 | 1.88M | $500.14M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ASND
- Fidelity Management & Research (FMR) 3.55M sh · $945.68M · Q2 2026
- BlackRock Inc 2.21M sh · $589.94M · Q2 2026
- Franklin Resources 1.86M sh · $496.77M · Q2 2026
- Wellington Management Group 1.55M sh · $413.05M · Q2 2026
- Capital World Investors 906.08K sh · $241.67M · Q2 2026
- Principal Global Investors 873.50K sh · $232.98M · Q2 2026
- Goldman Sachs Group 559.53K sh · $149.24M · Q2 2026
- Morgan Stanley 544.39K sh · $145.20M · Q2 2026
- Invesco Ltd 414.20K sh · $110.47M · Q2 2026
- Citadel Advisors 406.79K sh · $108.50M · Q2 2026
- Geode Capital Management 403.15K sh · $107.53M · Q2 2026